Cited by 1,226Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAging, Health, and Disability

The DOI matches its Crossref record.

Prevalence of Alzheimer's Disease in a Community Population of Older Persons: Higher Than Previously Reported

Evans, Denis A.·1989·JAMA

DOI 10.1001/jama.1989.03430180093036

Open this paper in CoChat — free account

Abstract

Clinically diagnosed Alzheimer's disease and other dementing illnesses were assessed in a geographically defined US community. Of 3623 persons (80.8% of all community residents over 65 years of age) who had brief memory testing in their homes, a stratified sample of 467 persons underwent neurological, neuropsychological, and laboratory examination. Prevalence rates of Alzheimer's disease were calculated for the community population from the sample undergoing clinical evaluation. Of those over the age of 65 years, an estimated 10.3% (95% confidence limits, 8.1% and 12.5%) had probable Alzheimer's disease. This prevalence rate was strongly associated with age. Of those 65 to 74 years old, 3.0% (95% confidence limits, 0.8 and 5.2) had probable Alzheimer's disease, compared with 18.7% (95% confidence limits, 13.2 and 24.2) of those 75 to 84 years old and 47.2% (95% confidence limits, 37.0 and 63.2) of those over 85 years. Other dementing conditions were uncommon. Of community residents with moderate or severe cognitive impairment, 84.1% had clinically diagnosed Alzheimer's disease as the only probable diagnosis. These data suggest that clinically diagnosed Alzheimer's disease is a common condition and that its public health impact will continue to increase with increasing longevity of the population. (JAMA. 1989;262:2551-2556)

Integrity signals

Registry

Crossref · 10.1001/jama.1989.03430180093036

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 601–700 of 1,000

PROTON MR SPECTROSCOPY IN ISCHEMIC STROKE AND OTHER VASCULAR DISORDERS
Ricci, P. E. (1998) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00546-5 · Cited by 26
Late-life depression: a neuropsychiatric approach
Burgut, F. T., Benaur, M., & Henchcliffe, C. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.1.65 · Cited by 26
Delirium
Liptzin, B., Levkoff, S. E., Gottlieb, G. L., et al. (1993) · Journal of Neuropsychiatry · doi:10.1176/jnp.5.2.154 · Cited by 26
Chemiluminescent high-throughput microassay for evaluation of acetylcholinesterase inhibitors
Guardigli, M., Pasini, P., Mirasoli, M., Leoni, A., Andreani, A., & Roda, A. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2004.12.016 · Cited by 26
Cognitive Predictors of Resistiveness in Dementia Patients
Stewart, J. T., Gonzalez-Perez, E., Zhu, Y., & Robinson, B. E. (1999) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199908000-00011 · Cited by 26
Risk of Antipsychotic Drug Use in Patients with Alzheimer???s Disease Treated with Rivastigmine
Suh, D., Arcona, S., Thomas, S. K., et al. (2004) · Drugs & Aging · doi:10.2165/00002512-200421060-00004 · Cited by 26
THE DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE: Cerebral Atrophy versus Normal Pressure Hydrocephalus
GEORGE, A. E., Holodny, A. I., Golomb, J. B., & de Leon, M. J. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00273-4 · Cited by 24
Aluminium and Alzheimer's Disease
Wisniewski, H. M., & Wen, G. Y. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514306.ch9 · Cited by 26
Patient characteristics in support: Activity status and cognitive function
Phillips, R. S., Goldman, L., & Bergner, M. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90215-b · Cited by 26
The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related Caspase Pathway
Li, L., Du, J., Zou, L., Xia, H., Wu, T., Kim, Y.-H., & Lee, Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1623-0 · Cited by 26
“Alzheimer’s disease (AD) is themost common form of senile dementia, affecting millions of people worldwide [11].”
Icarisid II rescues cognitive dysfunction via activation of Wnt/β‐catenin signaling pathway promoting hippocampal neurogenesis in APP / PS1 transgenic mice
Xiao, H., Chen, J., Li, H., Li, R., Wang, H., Song, H., Li, H., Shan, G., Tian, Y., Zhao, Y., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7430 · Cited by 25
Test Your Memory—Spanish version (TYM‐S): a validation study of a self‐administered cognitive screening test
Muñoz‐Neira, C., Henríquez, F., Delgado, C., Brown, J. M., & Slachevsky, A. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4055 · Cited by 28
“Prevalence of dementia increases exponentially with age, affecting approximately one in 10 people over the age of 65 years and half of people over 85 years (Evans et al., 1989; Fitzpatrick et al., 2004).”
Background
Neuroprotection and Neurodegeneration in Alzheimer’s Disease: Role of Cardiovascular Disease Risk Factors, Implications for Dementia Rates, and Prevention with Aerobic Exercise in African Americans
Obisesan, T. O., Gillum, R. F., Johnson, S., Umar, N. A., Williams, D., Bond, V., & Kwagyan, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/568382 · Cited by 26
“The prevalence of AD increased about 15-fold from 3 percent among individuals between the ages of 65, and 74 years to 47 percent for persons age 85 and older [3].”
Background
Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer’s Disease
Yumoto, S., Kakimi, S., & Ishikawa, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171108 · Cited by 25
Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein
Li, G., Zou, L., Jack, C. R., Yang, Y., & Yang, E. S. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.005 · Cited by 25
Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail
Andersen, F., Engstad, T. A., Straume, B., et al. (2010) · BMC Medical Research Methodology · doi:10.1186/1471-2288-10-35 · Cited by 25
“The incidence increases from <1% among people 65-69 years of age to nearly 9% above 85, making AD a major cause of disability in the elderly [1,2].”
Background
Progesterone reduces depression-like behavior in a murine model of Alzheimer’s Disease
Frye, C. A., & Walf, A. A. (2009) · AGE · doi:10.1007/s11357-009-9091-6 · Cited by 25
“Alzheimer’s Disease (AD) is the most common form of neurodegeneration among the elderly ( Evans et al. 1989 ) and may be influenced by sex steroids.”
Background
Apolipoprotein E4 and Alzheimer's disease in São Paulo - Brazil
Almeida, O. P., & Shimokomaki, C. M. (1997) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1997000100001 · Cited by 25
The Costs and Benefits of a Screening Program to Detect Dementia in Older Drivers
Retchin, S. M., & Hillner, B. E. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400402 · Cited by 25
Factors Associated with Inconsistent Diagnosis of Dementia Between Physicians and Neuropsychologists
MacKnight, C., Graham, J., & Rockwood, K. J. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb07428.x · Cited by 25
Alzheimer’s disease
Albert, M., & Drachman, D. A. (2000) · Neurology · doi:10.1212/wnl.55.2.166 · Cited by 25
Do susceptibility loci contribute to the expression of more than one mental disorder? A view from the genetics of Alzheimer's disease
Zubenko, G. S. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000713 · Cited by 25
Risk factors for clinically diagnosed alzheimer's disease
Baker, F. M., Jordan, B. D., Barclay, L., et al. (1993) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930080503 · Cited by 25
Effectiveness of Special Care Unit (SCU) placements in reducing physically aggressive behaviors in recently admitted dementia nursing home residents
Leon, J., & Ory, M. G. (1999) · American Journal of Alzheimer's Disease · doi:10.1177/153331759901400503 · Cited by 24
“(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)”
Reality Orientation Thirty Years Later: Are We Still Confused?
Bowlby, M. C. (1991) · Canadian Journal of Occupational Therapy · doi:10.1177/000841749105800303 · Cited by 24
“Recent research confirms that the numbers of those over 65 affected by ADRD is reaching epidemic propo rtions (Evans et al. 1989).”
Background
Distinct regional age effects on [ 11 C]AZ10419369 binding to 5-HT 1B receptors in the human brain
Nord, M., Cselényi, Z., Forsberg, A., Rosenqvist, G., Tiger, M., Lundberg, J., Varrone, A., & Farde, L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.040 · Cited by 24
“While the prevalence of both AD and PD is strongly associated with age (Evans et al., 1989; Fritsch et al., 2012), the prevalence of depressive and anxiety disorders is high also in the younger adult population (Kessler et al., 2005).”
Background
Educating medical students on Alzheimer's disease and related disorders: An overview of the Northwestern University Buddy Program
Morhardt, D. (2006) · Dementia · doi:10.1177/147130120600500311 · Cited by 24
“One of the most common problems of old age is dementia, a condition that increases in prevalence with age and is estimated to affect around half of those aged 85 and over (Berr, Wancata, & Ritchie, 2005; Evans et al., 1989; Rice et al., 2001).”
Background
Alzheimer's disease: epidemiology
Mayeux, R. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01218-3 · Cited by 25
Loneliness, Depressive Symptoms, and Cognitive Functioning Among U.S. Chinese Older Adults
Kong, D., Davitt, J. K., & Dong, X. (2018) · Gerontology and Geriatric Medicine · doi:10.1177/2333721418778201 · Cited by 24
“Those participants who recalled four or less ideas on immediate recall were asked to retell the story again after a distracting task about 3 min later (Evans et al., 1989; Scherr et al., 1988).”
Background
Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset
Chen, L., Baum, L., Ng, H., Chan, L. Y. S., & Pang, C. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90034-5 · Cited by 24
Cost comparisons between family‐based care and nursing home care for dementia
Chiu, L., Tang, K., Liu, Y., et al. (1999) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1999.00969.x · Cited by 24
Alzheimer’s disease: a review concerning immune response and microischemia
Chorsky, R. L., Yaghmai, F., Hill, W., & Stopa, E. G. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1148 · Cited by 24
Hospital and Nursing Home Use in the Last Three Months of Life
Brock, D. B., Foley, D. J., & Salive, M. E. (1996) · Journal of Aging and Health · doi:10.1177/089826439600800301 · Cited by 24
Parkinsonian signs and mortality from Alzheimer's disease
Bennett, D. A., Beckett, L. A., Wilson, R. S., Murray, A. M., & Evans, D. A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77686-8 · Cited by 24
Self-citation
Terminal Care for Noncancer Patients
von Gunten, C. F., & Twaddle, M. L. (1996) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30231-3 · Cited by 24
Does estrogen replacement therapy protect against Alzheimer's disease?
Paganini‐Hill, A. (1997) · Osteoporosis International · doi:10.1007/bf01674807 · Cited by 23
“In women over age 85 years, 30-50% may suffer from dementia [2].”
Background
A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice
Kelliny, S., Lin, L., Deng, I. B., Xiong, J., Zhou, F. H., Al‐Hawwas, M., Bobrovskaya, L., & Zhou, X. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02338-5 · Cited by 23
Folic Acid Inhibits Aging-Induced Telomere Attrition and Apoptosis in Astrocytes In Vivo and In Vitro
Li, Z., Zhou, D., Zhang, D., Zhao, J., Li, W., Sun, Y., Chen, Y., Liu, H., Wilson, J. X., Qian, Z., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab208 · Cited by 23
The prevalence of dementia and cognitive deficit in a rural population of 2442 residents in northern Italy. A door‐to‐door survey
Cristina, S., Nicolosi, A., Hauser, W. A., et al. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00301.x · Cited by 23
Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50
Aboud, O., Parcon, P. A., DeWall, K. M., Liu, L., Mrak, R. E., & Griffin, W. S. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00103 · Cited by 23
Insulin signaling in Drosophila melanogaster mediates Aβ toxicity
Huang, Y., Wan, Z., Wang, Z., & Zhou, B. (2018) · Communications Biology · doi:10.1038/s42003-018-0253-x · Cited by 23
“(2) Aβ inhibits the degradation of insulin.”
Background
Glycosaminoglycan‐induced activation of the β‐secretase (BACE1) of Alzheimer’s disease
Klaver, D. W., Wilce, M. C. J., Gasperini, R., Freeman, C. G., Juliano, J. P., Parish, C. R., Foa, L. C., Aguilar, M., & Small, D. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06571.x · Cited by 23
Medicare Expenditures Associated with Alzheimer Disease
Kane, R. L., & Atherly, A. J. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200010000-00001 · Cited by 23
“An east Boston study found substantially higher age-specific prevalence rates for dementia (per 100 population) of 3.0, 18.7, and 47.2 (Evans et al., 1989).”
BackgroundInfluential
Alzheimer's disease in women
Filley, C. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)80003-8 · Cited by 23
Episodic memory function in advanced aging and early Alzheimer's disease
Cullum, C. M., Filley, C. M., & Kozora, E. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000151 · Cited by 23
Conceptualizing Psychological Well‐Being in Cognitively‐Impaired Older Persons
Burgener, S. C., & Chiverton, P. A. (1992) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.1992.tb00720.x · Cited by 23
Thyroid Disease and Associated Illness in the Elderly
Shetty, K. R., & Duthie, E. H. (1995) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30299-4 · Cited by 23
Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against Aβ(25–35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals
Chen, T., Tang, M.-C., Chou, C.-H., Chiu, M., & Huang, R.-F. S. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.09.015 · Cited by 22
“Alzheimer’s disease (AD) is the most common form of neuronal degeneration disease associated with dementia among older adults (Evans et al., 1989).”
Background
Investigating the Medial Temporal Lobe in Alzheimer’s Disease and Mild Cognitive Impairment, with Turboprop Diffusion Tensor Imaging, MRI-volumetry, and T 2-relaxometry
Arfanakis, K., Gui, M., Tamhane, A. A., & Carew, J. D. (2007) · Brain Imaging and Behavior · doi:10.1007/s11682-007-9001-4 · Cited by 22
“Alzheimer’s disease (AD) is the most common dementia, afflicting approximately 10% of the population over the age of 65 and almost 50% of the population over 85 (Evans et al. 1989).”
Background
A Contextual Model of Restraint-Free Care for Persons with Dementia
Fisher, J. E., Drossel, C., Yury, C. A., & Cherup, S. (2007) · Elsevier eBooks · doi:10.1016/b978-012372544-8/50013-6 · Cited by 22
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease
Moreira, P. I., Zhu, X., Lee, H., Honda, K., Smith, M. A., & Perry, G. L. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.024 · Cited by 22
Educating primary care physicians in the management of Alzheimer's disease: using practice guidelines to set quality benchmarks
Cherry, D., Hahn, C., & Vickrey, B. G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008692 · Cited by 22
Cognitively Impaired Spouses as Primary Caregivers for Demented Elderly People
Boucher, L., Renvall, J., & Jackson, J. E. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb03742.x · Cited by 22
“Informal support systems included (1) children involved with the family either by phone or by periodic visits; (2) support through social activities participated in by the married couple; or (3) a friend who helped.”
Background
Caregivers Dependent upon Drivers with Dementia
Adler, G., Rottunda, S. J., Rasmussen, K., et al. (2000) · Journal of Clinical Geropsychology · doi:10.1023/a:1009532408845 · Cited by 22
Can estrogen play a significant role in the prevention of Alzheimer’s disease?
Kesslak, J. P. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_21 · Cited by 22
Future scenarios for the prevention and delay of alzheimer disease onset in high-risk groups:
Post, S. G. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00139-1 · Cited by 22
Magnetic resonance imaging of Alzheimer's disease
Xanthakos, S. A., Krishnan, K. R. R., Kim, D. M., & Charles, H. C. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(96)00035-8 · Cited by 22
Recognition of Dementia: Discovering the Silent Epidemic
Larson, E. B. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01546.x · Cited by 22
The Driver With Dementia: A Review of the Literature
Adler, G., Rottunda, S. J., & Dysken, M. W. (1996) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199621420-00003 · Cited by 22
Prevalence of Alzheimer dementia in Upper Egypt (desert areas)
Tallawy, H. N. E., Farghaly, W. M. A., Hamed, M. A. E., Badry, R., Usama, K., Shehata, G. A., Tohamy, A. M., Abdulghani, K. O., Ghanem, M. K., Sayed, M. A., et al. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0074-y · Cited by 21
Amyloid Beta Influences Vascular Smooth Muscle Contractility and Mechanoadaptation
Hald, E. S., Timm, C. D., & Alford, P. W. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4034560 · Cited by 21
Neurochemical imaging of dementias
Minoshima, S., Frey, K. A., Cross, D. J., & Kuhl, D. E. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2003.09.008 · Cited by 20
“There are 2 classes of benzodiazepine receptors: 1) central and (2) peripheral types.”
Background
Neuropsychological Detection of Early Probable Alzheimer’s Disease
Rentz, D. M., & Weıntraub, S. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_8 · Cited by 21
Pain and Psychological Function in Late Life
Parmelee, P. A. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0283-2_10 · Cited by 22
Hearing Impairment and Psychosis
Stein, L. M., & Thienhaus, O. J. (1993) · International Psychogeriatrics · doi:10.1017/s1041610293001383 · Cited by 21
Chapter 4: Cholinergic systems: human diseases, animal models, and prospects for therapy
Price, D. L., Koliatsos, V. E., & Clatterbuck, R. E. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62380-8 · Cited by 21
The Use of AF64A (Ethylcholine Aziridinium Ion) to Model Alzheimer’s Disease
Walsh, T. J., & Opello, K. D. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_9 · Cited by 21
Alzheimer's disease and cognitively impaired elderly: providing dental care.
Henry, R. G. (1999) · Journal - California Dental Association · doi:10.1080/19424396.2016.12221166 · Cited by 7
Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers
Petok, J. R., Myers, C. E., Pa, J., Hobel, Z. B., Wharton, D., Medina, L. D., Casado, M., Coppola, G., Gluck, M. A., & Ringman, J. M. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.022 · Cited by 21
“Early identification of incipient symptoms is of particular interest in cases of late-onset AD (LOAD)dthe most common form of the disease whose incidence increases after the age of 65 years to involve over 40% of persons aged 85 years and above (Evans et al., 1989).”
Background
A free radical‐generating system regulates APP metabolism/processing
Recuero, M., Muñoz‐Galdeano, T., Aldudo, J., Subías, M., Bullido, M. J., & Valdivieso, F. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.028 · Cited by 20
Confounding in the estimation of mediation effects
Li, Y., Bienias, J. L., & Bennett, D. A. (2006) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2006.10.016 · Cited by 20
“Fewer than 5 percent of men and women ages 65 to 74 have AD, and nearly half of those age 85 and older may have the disease (Evans et al., 1989).”
Background
Does the current consent process minimize the risks of genetics research?
Wendler, D., Prasad, K., & Wilfond, B. S. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10818 · Cited by 20
Chapter 8; Alzheimer's Disease and Related Dementias
Sanders, S., & Morano, C. (2008) · Journal of gerontological social work · doi:10.1080/01634370802137900 · Cited by 33
Willingness to be Screened and Tested for Cognitive Impairment: Cross-Cultural Comparison
Williams, C. L., Tappen, R. M., Rosselli, M., Keane, F., & Newlin, K. (2009) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317509352333 · Cited by 20
Functional Connectivity of Hippocampal CA3 Predicts Neurocognitive Aging via CA1–Frontal Circuit
Liang, X., Hsu, L., Lu, H., Ash, J. A., Rapp, P. R., & Yang, Y. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa008 · Cited by 20
Neuropsychology in Alzheimer's disease and other dementia research
Savla, G. N., & Palmer, B. W. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000184413.36706.8e · Cited by 20
Pharmacotherapy of Cognitive Impairment in Alzheimer's Disease: A Review
Patel, S. (1995) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879500800202 · Cited by 19
Clinical and neurobiological correlates of D10S1423 genotype in Alzheimer’s disease
Zubenko, G. S., Hughes, H. B., & Stiffler, J. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00021-9 · Cited by 19
Prevalence of dementia among elderly people in Troina, Sicily
D’Alessandro, R., Pandolfo, G., Azzimondi, G., et al. (1996) · European Journal of Epidemiology · doi:10.1007/bf00499458 · Cited by 20
“5% [1] to over 30% [2] among people over 74 years of age.”
Lifetime Risk and Duration of Chronic Disease and Disability
Murtaugh, C. M., Spillman, B. C., & Wang, X. (2010) · Journal of Aging and Health · doi:10.1177/0898264310389491 · Cited by 21
“However, the latter appears to be by far the main cause of moderate to severe cognitive impairment among elders, followed by multiple cerebral infarcts (Evans et al., 1989; Larson et al., 2004).”
Background
NMR Identification of the Formic Acid‐Modified Residue in Alzheimer's Amyloid Protein
Klunk, W. E., Xu, C., & Pettegrew, J. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010349.x · Cited by 20
Frequency, distribution, and risk factors for Alzheimer's disease.
Rocca, W. (1994) · The Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02715-3 · Cited by 21
Evidence for Psychotropic Effects of Acetylcholinesterase Inhibitors
Cummings, J. L., & Askin-Edgar, S. (2000) · CNS Drugs · doi:10.2165/00023210-200013060-00001 · Cited by 20
Comorbidity of other chronic age-dependent diseases in dementia
Thorpe, J., Widman, L. P., Wallin, A., Beiswanger, J., & Herman, T. (1994) · Aging Clinical and Experimental Research · doi:10.1007/bf03324233 · Cited by 19
Monitoring Alzheimer’s disease via ultraweak photon emission
Sefati, N., Esmaeilpour, T., Salari, V., Zarifkar, A., Dehghani, F., Ghaffari, M. K., Zadeh‐Haghighi, H., Császár, N., Bókkon, I., Rodrigues, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108744 · Cited by 20
“13 Among the pharmacological agents, acetylcholinesterase (AChE) inhibitors, like donepezil, seem to be the most effective agent for improving cholinergic deﬁcits and reducing the symptoms of AD.”
Background
A longitudinal study of home care clients and their informal carers
Armstrong-Esther, C., Hagen, B. F., Sandilands, M. L., et al. (2005) · British Journal of Community Nursing · doi:10.12968/bjcn.2005.10.6.18169 · Cited by 19
Diagnosing psychiatric emergencies in the elderly
Tueth, M. J. (1994) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(94)90162-7 · Cited by 19
Investigation of α-phenylnorstatine and α-benzylnorstatine as transition state isostere motifs in the search for new BACE-1 inhibitors
Wångsell, F., Nordeman, P., Sävmarker, J., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.11.042 · Cited by 19
Reliability of Peak Treadmill Exercise Tests in Mild Alzheimer Disease
Anderson, H. S., Kluding, P. M., Gajewski, B. J., Donnelly, J. E., & Burns, J. M. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.574762 · Cited by 20
“KEYWORDS: Alzheimer’s disease, cardiorespiratory fitness, dementia, fitness, VO2 The prevalence of Alzheimer’s disease (AD) doubles every five years after the age of 65, reaching nearly 50% after age 85 (Evans et al., 1989).”
Neurodegenerative Diseases
Cochran, E. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0949-0.00006-6 · Cited by 19
Buspirone in the Management of Disruptive Behaviors Due to Huntington's Disease and Other Neurological Disorders
Bhandary, A. N., & Masand, P. S. (1997) · Psychosomatics · doi:10.1016/s0033-3182(97)71447-6 · Cited by 19
γ-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neurons
Minogue, A. M., Stubbs, A. K., Frigerio, C. S., Boland, B., Fadeeva, J. V., Tang, J., Selkoe, D. J., & Walsh, D. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.008 · Cited by 20
Elderly Japanese emigrants to Brazil before World War II: II. prevalence of senile dementia
Meguro, K., Meguro, M., Caramelli, P., Ishizaki, J., Ambo, H., Chubaci, R. Y. S., Hamada, G. S., Nitríni, R., & Yamadori, A. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.430 · Cited by 23
Stains for the Differential Diagnosis of Degenerative Dementias
Muñoz, D. G. (1999) · Biotechnic & Histochemistry · doi:10.3109/10520299909034668 · Cited by 19
Alzheimer's Disease and Brain Reserve
Schofield, P. (1999) · Australian Journal on Ageing · doi:10.1111/j.1741-6612.1999.tb00081.x · Cited by 22
Aluminium and the Pathogenesis of Alzheimer's Disease: A Summary of Evidence
McLachlan, D. R. C., Fraser, P. E., & Dalton, A. J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514306.ch6 · Cited by 19
The effect of PN-1, a Traditional Chinese Prescription, on the Learning and Memory in a Transgenic Mouse Model of Alzheimer’s Disease
Yao, Z., Zhang, L., Liang, L., Liu, Y., Yang, Y., Huang, L., Zhu, H., Ma, C., & Qin, C. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/518421 · Cited by 19
“As the most common type of dementia in western medicine, AD is a neurodegenerative disorder characterized clinically by progressive memory loss and neuropathologically by extracellular amyloid plaques [6].”
Background
Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer’s Disease: The Human Brain Outside the Dish
Tong, G., Izquierdo, P., & Raashid, R. A. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010027 · Cited by 18
“The prevalence rates of AD-related dementia also rise substantially with age particularly between 65-80 years [2].”
Background
FAD Mutations in Amyloid Precursor Protein Do Not Directly Perturb Intracellular Calcium Homeostasis
Stieren, E. S., Werchan, W. P., Ayadi, A. E., Li, F., & Boehning, D. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011992 · Cited by 18
Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of β-secretase (BACE1)
Huber, T., Manzenrieder, F., Kuttruff, C. A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.053 · Cited by 18

Authors: Evans, D. A.
Corresponding author: Evans, Denis A.
ORCID: Evans, Denis A.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1989-11-10
Volume: 262
Issue: 18
Pages: 2551
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1989.03430180093036
OpenAlex: W2129678592
Cited by: 1,226
References: 0
Citations by year: 2026: 6 · 2025: 11 · 2024: 13 · 2023: 15 · 2022: 9 · 2021: 20 · 2020: 22 · 2019: 17 · 2018: 20 · 2017: 18 · 2016: 28 · 2015: 23 · 2014: 17 · 2013: 32 · 2012: 25
FWCI: 44.57
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Funders: National Institute on Aging (N01-AG02107, N01‐AG‐1‐2106, AG 06789)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
Keywords: Alzheimer's disease, prevalence, older adults, dementia, age-related cognitive decline, community-dwelling older adults, cognitive impairment, age differences in prevalence, public health impact

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of Alzheimer's Disease in a Community Population of Older Persons: Higher Than Previously Reported

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks